NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS | The EMBO Journal
Cells | Free Full-Text | The NF-κB Pathway and Cancer Stem Cells
State of play in amyotrophic lateral sclerosis genetics | Nature Neuroscience
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury | Cell Death & Disease
IJMS | Free Full-Text | The Links between ALS and NF-κB
Cells | Free Full-Text | The Regulation of NF-κB Subunits by Phosphorylation
Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling | Journal of Neuroscience
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis - The Lancet Neurology
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers | Nature Reviews Neurology
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
IJMS | Free Full-Text | The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation | Nature Reviews Drug Discovery
Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis | ACS Chemical Neuroscience
Frontiers | Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
Frontiers | Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis
Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling | Journal of Neuroscience
Frontiers | The Safety and Efficacy of Stem Cell Therapy as an Emerging Therapy for ALS: A Systematic Review of Controlled Clinical Trials
Cells | Free Full-Text | Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Cells | Free Full-Text | Hypoxia Induced NF-κB
IJMS | Free Full-Text | Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis | Journal of Medicinal Chemistry
Recombinant Human NF-kB p65 protein (ABIN2730698)
Gene therapy for ALS: A review: Molecular Therapy
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies | Nature Reviews Genetics
Frontiers | Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway
Cells | Free Full-Text | Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance
Frontiers | Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis
